Microsponge based Montelukast sodium Transdermal Hydrogel

Montelukast sodium is available in oral conventional tablets, chewable tablets, and granules. Which has low bioavailability and it also causes temporary numbness upon oral administration. We made an attempt to overcome the problems by formulating montelukast sodium microsponge based hydrogels for transdermal delivery. The repeated administration can also be avoided and the patient compliance can be enhanced by sustaining the drug release and also decrease the dose. Thus the research work the formulation technique used was reproducible and the formulations were safe and efficient as vehicles for drug for transdermal delivery of drug over a period of 24 hours.

Autorentext

A Dra. Bhavani (Asso Prof) tem 10 anos de experiência de ensino e geriu um projeto como Investigadora Principal, WOS-A, DST. Publicou mais de 40 artigos nacionais e internacionais. Recebeu várias bolsas de viagem internacionais. A Dra. Swathi tem 7 anos de experiência em investigação e foi premiada com CSIR SRF e UGC PDF. Tem mais de 50 publicações.